Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hunstein

Showing results (101-110 of 190) with videos related to

Pageof 19
Sort By:
Zeitschrift Fur Rheumatologie|November 1, 1982
[Immunohistological and histological findings in the temporal artery in polymyalgia rheumatica]E Roth, W Hunstein, H P Seelig, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1984
The influence of radiation therapy on T-lymphocyte subpopulations defined by monoclonal antibodiesG Job, M Pfreundschuh, M Bauer, et al.
Deutsche Medizinische Wochenschrift (1946)|May 31, 1985
[Plasmacytomas without paraproteins]A D Ho, A Pezzutto, B Dörken, et al.
Clinical Physiology and Biochemistry|January 1, 1986
Intracellular sodium concentration and transport in red cells in essential hypertension, hyperthyroidism, pregnancy and hypokalemiaK H Gless, U Sütterlin, K Schaz, et al.
Acta Haematologica|January 1, 1977
Acquired pyruvate kinase deficiency with hemolysis in preleukemiaV Helmstädter, H Arnold, K G Blume, et al.
Deutsche Medizinische Wochenschrift (1946)|May 30, 1986
[Results with the use of the M-2 protocol in plasmacytoma]A D Ho, S Wittkamp, H Theml, et al.
Oncology|January 1, 1983
Effect of cytotoxic drugs on the function of the hypothalamo-pituitary-adrenal axisM Pfreundschuh, K H Gless, B Dörken, et al.
Klinische Wochenschrift|October 15, 1987
2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alphaA D Ho, R Kuse, O Prümmer, et al.
The Journal of Investigative Dermatology|December 1, 1993
Hematogenous spread of malignant melanoma cells in different stages of diseaseP Brossart, U Keilholz, M Willhauck, et al.
Melanoma Research|June 1, 1994
HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2)C Scheibenbogen, U Keilholz, J Mytilineos, et al.
Pageof 19

Showing results (101-110 of 190) with videos related to

Sort By:
Pageof 19
Zeitschrift Fur Rheumatologie|November 1, 1982
[Immunohistological and histological findings in the temporal artery in polymyalgia rheumatica]E Roth, W Hunstein, H P Seelig, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1984
The influence of radiation therapy on T-lymphocyte subpopulations defined by monoclonal antibodiesG Job, M Pfreundschuh, M Bauer, et al.
Deutsche Medizinische Wochenschrift (1946)|May 31, 1985
[Plasmacytomas without paraproteins]A D Ho, A Pezzutto, B Dörken, et al.
Clinical Physiology and Biochemistry|January 1, 1986
Intracellular sodium concentration and transport in red cells in essential hypertension, hyperthyroidism, pregnancy and hypokalemiaK H Gless, U Sütterlin, K Schaz, et al.
Acta Haematologica|January 1, 1977
Acquired pyruvate kinase deficiency with hemolysis in preleukemiaV Helmstädter, H Arnold, K G Blume, et al.
Deutsche Medizinische Wochenschrift (1946)|May 30, 1986
[Results with the use of the M-2 protocol in plasmacytoma]A D Ho, S Wittkamp, H Theml, et al.
Oncology|January 1, 1983
Effect of cytotoxic drugs on the function of the hypothalamo-pituitary-adrenal axisM Pfreundschuh, K H Gless, B Dörken, et al.
Klinische Wochenschrift|October 15, 1987
2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alphaA D Ho, R Kuse, O Prümmer, et al.
The Journal of Investigative Dermatology|December 1, 1993
Hematogenous spread of malignant melanoma cells in different stages of diseaseP Brossart, U Keilholz, M Willhauck, et al.
Melanoma Research|June 1, 1994
HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2)C Scheibenbogen, U Keilholz, J Mytilineos, et al.
Pageof 19